Cipla Ltd, a Mumbai-based drugmaker, has signed an agreement to sell its entire 25 per cent stake in Biomab Holding Limited (BHL), Hong Kong to Biomab Brilliant Ltd, British Virgin Islands, for $25.8 million, according to a stock market disclosure. The deal is subject to various regulatory approvals.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
